APA (7. basım) Alıntı

Nicum, S., Roberts, C., Boyle, L., Kopijasz, S., Gourley, C., Hall, M., . . . Dutton, S. (2014). A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: A study protocol. BioMed Central.

Chicago Style (17. basım) Atıf

Nicum, S., et al. A Phase II Clinical Trial of 6-mercaptopurine (6MP) and Methotrexate in Patients with BRCA Defective Tumours: A Study Protocol. BioMed Central, 2014.

MLA (9th ed.) Atıf

Nicum, S., et al. A Phase II Clinical Trial of 6-mercaptopurine (6MP) and Methotrexate in Patients with BRCA Defective Tumours: A Study Protocol. BioMed Central, 2014.